These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16215614)

  • 1. [Genetic variation-- important for the clinical effect of opioids?].
    Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variability and clinical efficacy of morphine.
    Klepstad P; Dale O; Skorpen F; Borchgrevink PC; Kaasa S
    Acta Anaesthesiol Scand; 2005 Aug; 49(7):902-8. PubMed ID: 16045647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic polymorphisms and human sensitivity to pain and opioids].
    Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
    Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of opioids.
    Somogyi AA; Barratt DT; Coller JK
    Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects.
    Kolesnikov Y; Gabovits B; Levin A; Voiko E; Veske A
    Anesth Analg; 2011 Feb; 112(2):448-53. PubMed ID: 21127283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in interpreting joined allelic combinations of OPRM1 and COMT genes.
    Landau R; Ortner C; Carvalho B
    Anesth Analg; 2011 Aug; 113(2):432. PubMed ID: 21788333
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics of morphine: Potential implications in sickle cell disease.
    Darbari DS; Minniti CP; Rana S; van den Anker J
    Am J Hematol; 2008 Mar; 83(3):233-6. PubMed ID: 17722074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
    Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
    Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Side effects of opioid and gene variants].
    Sora I; Komatsu H; Igari M; Ide S; Ikeda K; Shimoyama N
    Masui; 2009 Sep; 58(9):1109-11. PubMed ID: 19764433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of genetic factors on opioid action.
    Kosarac B; Fox AA; Collard CD
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects.
    Ross JR; Riley J; Taegetmeyer AB; Sato H; Gretton S; du Bois RM; Welsh KI
    Cancer; 2008 Mar; 112(6):1390-403. PubMed ID: 18257092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic factors in pain and its treatment.
    Stamer UM; Stüber F
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain.
    De Gregori M; Garbin G; De Gregori S; Minella CE; Bugada D; Lisa A; Govoni S; Regazzi M; Allegri M; Ranzani GN
    Eur J Clin Pharmacol; 2013 Sep; 69(9):1651-8. PubMed ID: 23686330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers.
    Lötsch J; Geisslinger G
    Pharmacogenomics J; 2006; 6(3):200-10. PubMed ID: 16415919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
    Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
    Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics in pain management: the clinical need.
    Webster LR
    Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.
    Adegbola MA
    Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics in palliative care.
    Kleine-Brueggeney M; Musshoff F; Stuber F; Stamer UM
    Forensic Sci Int; 2010 Dec; 203(1-3):63-70. PubMed ID: 20709477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of opioid pharmacogenetics.
    Argoff CE
    Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental and genetic factors associated with morphine response in the postoperative period.
    Coulbault L; Beaussier M; Verstuyft C; Weickmans H; Dubert L; Trégouet D; Descot C; Parc Y; Lienhart A; Jaillon P; Becquemont L
    Clin Pharmacol Ther; 2006 Apr; 79(4):316-24. PubMed ID: 16580900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.